In the case of lung cancer, the drop in death rate is heavily dependent on the increase in new cancer therapies. While the drop in smoking rates years ago likely does influence the drop in lung cancer deaths, 2/3 of new lung cancer patients occur in non-smokers, and 20% of new cases occur in never smokers. In fact, the lung cancer death rate in young neversmoker females is actually increasing. The reduction in lung cancer deaths is disproportionately larger than the reduction in smoking rates. Please don’t let the stigma of smoking cloud your understanding of the very real difference these new therapies have made in lung cancer survival.
Also in Industry News
How to decide whether or not to start treatment for prostate cancer?
Analysis of the SARS-CoV-2 proteome via visual tools
$65m investment increases British Patient Capital’s exposure to life sciences and health technology